AzTrials
AzTrials

Ventricular Function, RightTEENCT03264183

Validating TEE Measurements of Right Ventricular Function

An observational study of Ventricular Function, Right and Echocardiography, Transesophageal, run by Milton S. Hershey Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Transesophageal echocardiography (TEE) is becoming a more prevalent method of monitoring and diagnosis in the perioperative setting for critically ill patients and patients undergoing cardiac surgery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Transesophageal Echocardiography and Transthoracic Echocardiography
How many people
126 participants
Where
1 siteUnited States
Study dates
18 Sep 2017to 10 Oct 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients undergoing elective cardiac surgery, which as a standard of care, requires transesophageal echocardiography.

Who may be able to join

  • Adult patients undergoing elective cardiac surgery requiring TEE

Who cannot join

  • Patient who do not wish to consent
  • Patients with contraindications to TEE
  • Urgent or emergent cardiac surgery
  • Patients with preexisting open chest
  • Patients with intrathoracic hardware (VAD, thoracostomy tube, etc)
  • Non-English speaking subjects
  • Cognitively impaired adults
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Milton S. Hershey Medical Center

    Hershey, Pennsylvania, 17033

Other trials in United States

About this study

Official title: Validating Transesophageal Echocardiographic Measurements of Right Ventricular Function

Transesophageal echocardiography (TEE) is becoming a more prevalent method of monitoring and diagnosis in the perioperative setting for critically ill patients and patients undergoing cardiac surgery. Many TEE measurements are extrapolated from transthoracic echocardiography (TTE) data and have not validated by transesophageal means. The aim of this study is to validate TEE assessment of right ventricular function by comparing them to simultaneously measured TTE measurements.

Likewise, there are currently no agreed upon values for RV free wall strain. Therefore, the investigators will attempt to define a range of normal values of RV free wall strain as compared to the other measures of RV function.

Read the detailed description

Traditionally, all echocardiographic measurements have been studied utilizing TTE. Therefore the normal values and ranges for pathology findings have been defined by transthoracic means alone. TEE offers different images planes when compared to TTE, which may make the measurements obtained differ from those obtained by TTE. In the operating room environment the vast majority of echocardiography is completed by transesophageal means for many reasons; largely access to the patient and the continuous use of TEE as a hemodynamic monitor. However, given the fact that most echocardiographic measurements have only been validated by TTE, there remains a question as to the validity or precision of TEE-derived measurements.

Being tested
Transesophageal Echocardiography, Transthoracic Echocardiography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transesophageal EchocardiographyDiagnostic test

    Also called TEE

    TEE measures of right ventricular function

  • Transthoracic EchocardiographyDiagnostic test

    Also called TTE

    TTE measures of right ventricular function

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Right ventricular index of myocardial performance (RIMP)

    Right ventricular index of myocardial performance (RIMP) will be measured using both TTE and TEE.

    Measured: Immediately following the induction of anesthesia and TEE probe placement

  2. Tricuspid annular plane systolic excursion (TAPSE)

    Tricuspid annular plane systolic excursion (TAPSE) will be measured using both TTE and TEE.

    Measured: Immediately following the induction of anesthesia and TEE probe placement

  3. Right ventricular fractional area change (FAC)

    Right ventricular fractional area change (FAC) will be measured using both TTE and TEE.

    Measured: Immediately following the induction of anesthesia and TEE probe placement

  4. RV annular systolic velocity (S')

    RV annular systolic velocity (S') will be measured using both TTE and TEE.

    Measured: Immediately following the induction of anesthesia and TEE probe placement

  5. RV free wall longitudinal strain

    RV free wall longitudinal strain will be measured using both TTE and TEE.

    Measured: Immediately following the induction of anesthesia and TEE probe placement

Secondary outcomes (2)
  1. Ease of obtaining appropriate TEE measures of right ventricular function

    Ease of acquisition will be assessed by the echocardiographers

    Measured: Within 15 minutes following anesthesia induction

  2. Define values for normal right ventricular free wall strain

    The data collected will be used to define normal values for right ventricular free wall strain

    Measured: Through study completion, an estimate of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2017
  2. Study start18 Sep 2017
  3. Primary completion10 Oct 2018
  4. Study completion10 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03264183
Sponsor's protocol ID
STUDY00007541
Acronym
TEE
Status last verified
Jun 2019
First submitted
26 Jul 2017
Last updated
24 Jun 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Barakat AF, Sperry BW, Starling RC, Mentias A, Popovic ZB, Griffin BP, Desai MY. Prognostic Utility of Right Ventricular Free Wall Strain in Low Risk Patients After Orthotopic Heart Transplantation. Am J Cardiol. 2017 Jun 1;119(11):1890-1896. doi: 10.1016/j.amjcard.2017.03.003. Epub 2017 Mar 15.

    PubMed 28390683
  • Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, Senni M, Clemenza F, Agnese V, Falletta C, Romano G, Maalouf J, Dandel M. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail. 2017 Jul;19(7):926-946. doi: 10.1002/ejhf.733. Epub 2017 Mar 31.

    PubMed 28371221
  • Howard-Quijano K, Salem A, Barkulis C, Mazor E, Scovotti JC, Ho JK, Shemin RJ, Grogan T, Elashoff D, Mahajan A. Preoperative Three-Dimensional Strain Imaging Identifies Reduction in Left Ventricular Function and Predicts Outcomes After Cardiac Surgery. Anesth Analg. 2017 Feb;124(2):419-428. doi: 10.1213/ANE.0000000000001440.

    PubMed 27782943
  • Kemal HS, Kayikcioglu M, Kultursay H, Vuran O, Nalbantgil S, Mogulkoc N, Can L. Right ventricular free-wall longitudinal speckle tracking strain in patients with pulmonary arterial hypertension under specific treatment. Echocardiography. 2017 Apr;34(4):530-536. doi: 10.1111/echo.13472. Epub 2017 Mar 23.

    PubMed 28332221
  • Peyrou J, Chauvel C, Pathak A, Simon M, Dehant P, Abergel E. Preoperative right ventricular dysfunction is a strong predictor of 3 years survival after cardiac surgery. Clin Res Cardiol. 2017 Sep;106(9):734-742. doi: 10.1007/s00392-017-1117-y. Epub 2017 Apr 13.

    PubMed 28409231
  • Sokalskis V, Peluso D, Jagodzinski A, Sinning C. Added clinical value of applying myocardial deformation imaging to assess right ventricular function. Echocardiography. 2017 Jun;34(6):919-927. doi: 10.1111/echo.13521. Epub 2017 Mar 19.

    PubMed 28317170
  • Tousignant C, Desmet M, Bowry R, Harrington AM, Cruz JD, Mazer CD. Speckle tracking for the intraoperative assessment of right ventricular function: a feasibility study. J Cardiothorac Vasc Anesth. 2010 Apr;24(2):275-9. doi: 10.1053/j.jvca.2009.10.022. Epub 2010 Jan 6.

    PubMed 20056440
  • Agac MT, Akyuz AR, Acar Z, Akdemir R, Korkmaz L, Kiris A, Erkus E, Erkan H, Celik S. Evaluation of right ventricular function in early period following transcatheter closure of atrial septal defect. Echocardiography. 2012 Mar;29(3):358-62. doi: 10.1111/j.1540-8175.2011.01558.x. Epub 2011 Nov 8.

    PubMed 22066780
  • Akiyama K, Arisawa S, Ide M, Iwaya M, Naito Y. Intraoperative cardiac assessment with transesophageal echocardiography for decision-making in cardiac anesthesia. Gen Thorac Cardiovasc Surg. 2013 Jun;61(6):320-9. doi: 10.1007/s11748-013-0208-6. Epub 2013 Feb 13.

    PubMed 23404310
  • Carerj S, Micari A, Trono A, Giordano G, Cerrito M, Zito C, Luzza F, Coglitore S, Arrigo F, Oreto G. Anatomical M-mode: an old-new technique. Echocardiography. 2003 May;20(4):357-61. doi: 10.1046/j.1540-8175.2003.03041.x.

    PubMed 12848879
  • Chan J, Wahi S, Cain P, Marwick TH. Anatomical M-mode: A novel technique for the quantitative evaluation of regional wall motion analysis during dobutamine echocardiography. Int J Card Imaging. 2000 Aug;16(4):247-55. doi: 10.1023/a:1026539708034.

    PubMed 11219596
  • David JS, Tousignant CP, Bowry R. Tricuspid annular velocity in patients undergoing cardiac operation using transesophageal echocardiography. J Am Soc Echocardiogr. 2006 Mar;19(3):329-34. doi: 10.1016/j.echo.2005.09.013.

    PubMed 16500497
  • Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013 Sep;26(9):921-64. doi: 10.1016/j.echo.2013.07.009. No abstract available.

    PubMed 23998692
  • Ito S, Pislaru SV, Soo WM, Huang R, Greason KL, Mathew V, Sandhu GS, Eleid MF, Suri RM, Oh JK, Nkomo VT. Impact of right ventricular size and function on survival following transcatheter aortic valve replacement. Int J Cardiol. 2016 Oct 15;221:269-74. doi: 10.1016/j.ijcard.2016.07.085. Epub 2016 Jul 6.

    PubMed 27404688
  • Magunia H, Schmid E, Hilberath JN, Haberle L, Grasshoff C, Schlensak C, Rosenberger P, Nowak-Machen M. 2D Echocardiographic Evaluation of Right Ventricular Function Correlates With 3D Volumetric Models in Cardiac Surgery Patients. J Cardiothorac Vasc Anesth. 2017 Apr;31(2):595-601. doi: 10.1053/j.jvca.2016.11.020. Epub 2016 Nov 14.

    PubMed 28129939

Questions about this trial

What is this clinical trial studying?

An observational study of Ventricular Function, Right and Echocardiography, Transesophageal, run by Milton S. Hershey Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Right ventricular index of myocardial performance (RIMP) (time frame: Immediately following the induction of anesthesia and TEE probe placement). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03264183, which also lists 28 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in